Results

Total Results: 41 records

Showing results for "pap smear".
Users also searched for: cervical cancer

  1. www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/cervical-cancer-screening-adults-adolescents
    December 10, 2024 - insurance and 25.5% of women with no regular healthcare clinician reported not receiving a Papanicolaou (Pap … years in 6,265 women who had a hysterectomy with removal of the cervix, screening yielded 104 abnormal Paptest results and no cases of cervical cancer; although, six cases of high-grade vaginal lesions were … Pap test use is lower among female-to-male patients than non-transgender women. … The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result.
  2. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review78/ovarian-cancer-screening-2012
    April 15, 2012 - cancer, mass screening, physical examination, tumor markers, ultrasound imaging, and vaginal smears or papsmear.
  3. JAMA JATS (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nvjr8BPsZhy4XGc7-rGjAH
    June 18, 2018 - women in the 2012 Behavioral Risk Factor Surveillance System reported not receiving a Papanicolaou [Pap … health insurance and 25.5% of women with no regular health care clinician reported not receiving a Paptest in the past 5 years, compared with 11.4% of the general population. … Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing … The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result.
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/fNXdu3HGvWE-ovsuhNeANW
    April 01, 2012 - cancer, mass screening, physical examination, tumor markers, ultrasound imaging, and vaginal smears or papsmear.
  5. www.uspreventiveservicestaskforce.org/uspstf/first-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services-appendix-c
    December 01, 2011 - Cancer: Screening in Women Who Have Had a Hysterectomy The USPSTF recommends against routine Papsmear screening in women who have had a total hysterectomy for benign disease.
  6. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/cervical-cancer-screening
    August 21, 2018 - hrHPV screening alone or hrHPV cotesting (both hrHPV testing and cytology) with cytology (Papanicolaou [Pap … ] test) screening alone. … USPSTF) recommended screening women aged 21 to 65 years for cervical cancer with cytology (Papanicolaou [Pap … ] smear) every 3 years, with an option for women 30 years and older for hrHPV cotesting (cytology and … Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing
  7. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary12/cervical-cancer-screening-2012
    October 18, 2011 - The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from … ThinPrep Pap Test Quick Reference Guide: Endocervical Brush/Spatula Protocol. … § HC2 and cytology reported as Papanicolaou test result of ASC-US+ or HPV ≥ 1 pg HPV DNA/mL.
  8. JAMA JATS (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/dvDjnZzW9PDxzKBauB4QxA
    August 21, 2018 - hrHPV screening alone or hrHPV cotesting (both hrHPV testing and cytology) with cytology (Papanicolaou [Pap … ] test) screening alone. … rec- ommended screening women aged 21 to 65 years for cervical cancer with cytology (Papanicolaou [Pap … ] smear) every 3 years, with an option for women 30 years and older for hrHPV co- testing (cytology and … Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing
  9. www.uspreventiveservicestaskforce.org/home/getfilebytoken/_9KLmyQyMnoE3agQJsgNE-
    November 01, 2011 - . § HC2 and cytology reported as Pap test result of ASC-US� or HPV �1 pg HPV DNA/mL. � Data were not … ThinPrep Pap Test Quick Reference Guide: Endocervical Brush/ Spatula Protocol. … The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from
  10. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4)_0.pdf
    January 01, 2016 - smear in the 1950s and 1960s. … In 2012, the USPSTF found convincing evidence that screening for cervical cancer with a Pap smear every … smear. … Years The USPSTF recommends screening for cervical cancer in women ages 21 to 65 years with cytology (Papsmear) every 3 years or, for women ages 30 to 65 years who want to lengthen the screening interval
  11. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4).pdf
    January 01, 2016 - smear in the 1950s and 1960s. … In 2012, the USPSTF found convincing evidence that screening for cervical cancer with a Pap smear every … smear. … Years The USPSTF recommends screening for cervical cancer in women ages 21 to 65 years with cytology (Papsmear) every 3 years or, for women ages 30 to 65 years who want to lengthen the screening interval
  12. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
    January 01, 2012 - recommendations apply to preventive services that are offered in a primary care setting (such as a Papsmear to detect cervical cancer), services that are available through primary care referral (such as … Cervical Cancer: Screening in Women Who Have Had a Hysterectomy The USPSTF recommends against routine Papsmear screening in women who have had a total hysterectomy for benign disease.
  13. www.uspreventiveservicestaskforce.org/home/getfilebytoken/k2QHcwuK4NkvxFXhvGrbwY
    May 01, 2004 - Screening for Ovarian Cancer: A Brief Evidence Update Background In 1996, the USPSTF stated that routine screening for ovarian cancer by ultrasound, the measurement of serum tumor markers, or pelvic examination was not recommended (D recommendation).1 There was insufficient evidence to recommend for or against the …
  14. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review79/ovarian-cancer-screening-2004
    May 15, 2004 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Review Ovarian Cancer: Screening, May 2004 May 15, 2004 Recommendations made by the USPSTF are independent of the U.S. government. They should no…
  15. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/rtc2016rev_2%20(3).pdf
    December 01, 2016 - An additional 10% of cases occur in women who did not have appropriate followup for an abnormal Papsmear. … Years The USPSTF recommends screening for cervical cancer in women ages 21 to 65 years with cytology (Papsmear) every 3 years or, for women ages 30 to 65 years who want to lengthen the screening interval,
  16. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annual-report-to-congress-2017%20(2).pdf
    January 01, 2017 - disorders for which the USPSTF already recommends screening (i.e., screening for cervical cancer with a Papanicolaousmear, screening for gonorrhea and chlamydia). … ) The USPSTF recommends screening for cervical cancer in women ages 21 to 65 years with cytology (Pap … disorders for which the USPSTF already recommends screening (screening for cervical cancer with a Papsmear, screening for gonorrhea and chlamydia).
  17. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2013%20(4).pdf
    November 01, 2013 - A Cervical Cancer: Screening in Women Ages 21 to 65 (Pap Smear) or 30 to 65 (With HPV Testing) The … USPSTF recommends screening for cervical cancer in women ages 21 to 65 years with cytology (Pap smear
  18. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
    November 01, 2014 - A The USPSTF recommends screening for cervical cancer in women ages 21 to 65 years with cytology (Papsmear) every 3 years or, for women ages 30 to 65 years who want to lengthen the screening interval
  19. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
    November 01, 2014 - A The USPSTF recommends screening for cervical cancer in women ages 21 to 65 years with cytology (Papsmear) every 3 years or, for women ages 30 to 65 years who want to lengthen the screening interval
  20. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
    January 01, 2018 - disorders for which the USPSTF already recommends screening (i.e., screening for cervical cancer with a Papsmear, screening for gonorrhea and chlamydia).

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: